CA-AI Echo – Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study

13 December 2024 (12:30 - 12:38)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Adam Ioannou

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail

DISCOVER SGLT2i - myocardial deformation and reverse remodelling after SGLT2 inhibitors

Doctor M. Pastore (Siena, IT)

Presentation thumbnail

Discussant review - DISCOVER SGLT2i

Professor A. Coisne (Lille, FR)

Presentation thumbnail

RV function following the TVARC recommendations

Mr X. Galloo (Brussels, BE)

Presentation thumbnail

Discussant review - RV function following the TVARC recommendations

Professor D. Augustine (Bath, GB)

Presentation thumbnail

MRI-Derived On-Screen Image Guidance Improves Left Ventricular Lead Placement Accuracy in Cardiac Resynchronization Therapy

Mr W. Gerrits (Utrecht, NL)

Access the full session

Session thumbnail

Late-Breaking Science

The Event

Event poster

EuroEcho-Imaging 2024

13 December 2024 12:30 CET

You may be interested in

Congress Presentation

Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.

Congress Presentation

Identification of at-risk populations for cardiac amyloidosis: a multimodal machine learning development and validation study

Congress Presentation

Detection and risk stratification of cardiac amyloidosis patients by integration of imaging and non-imaging data using a machine learning approach

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources